Stephen P Squinto - Net Worth and Insider Trading
Stephen P Squinto Net Worth
The estimated net worth of Stephen P Squinto is at least $24 Million dollars as of 2024-11-13. Stephen P Squinto is the EVP, Chief Global Ops. Officer of Alexion Pharmaceuticals Inc and owns about 106,508 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $19 Million. Stephen P Squinto is also the Director, 10% Owner of SpringWorks Therapeutics Inc and owns about 125,728 shares of SpringWorks Therapeutics Inc (SWTX) stock worth over $4 Million. Details can be seen in Stephen P Squinto's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen P Squinto has not made any transactions after 2021-04-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen P Squinto
Stephen P Squinto Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen P Squinto owns 6 companies in total, including SpringWorks Therapeutics Inc (SWTX) , Passage Bio Inc (PASG) , and Audentes Therapeutics Inc (BOLD) among others .
Click here to see the complete history of Stephen P Squinto’s form 4 insider trades.
Insider Ownership Summary of Stephen P Squinto
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SWTX | SpringWorks Therapeutics Inc | 2021-04-28 | director & 10 percent owner |
| PASG | Passage Bio Inc | 2020-02-27 | director & Head of Research and Dev |
| BOLD | Audentes Therapeutics Inc | 2017-10-08 | director |
 | | 2014-10-27 | EVP & Chief Global Ops. Officer |
| | 2021-03-16 | director |
| | 2020-08-06 | director |
Stephen P Squinto Latest Holdings Summary
Stephen P Squinto currently owns a total of 2 stocks. Among these stocks, Stephen P Squinto owns 106,508 shares of Alexion Pharmaceuticals Inc (ALXN) as of October 27, 2014, with a value of $19 Million and a weighting of 82.37%. Stephen P Squinto also owns 125,728 shares of SpringWorks Therapeutics Inc (SWTX) as of April 28, 2021, with a value of $4 Million and a weighting of 17.63%.
Latest Holdings of Stephen P Squinto
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2014-10-27 | 106,508 | 182.50 | 19,437,710 |
| SWTX | SpringWorks Therapeutics Inc | 2021-04-28 | 125,728 | 33.08 | 4,159,082 |
Holding Weightings of Stephen P Squinto
Stephen P Squinto Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen P Squinto has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 5,910 shares on October 27, 2014, which brought Stephen P Squinto around $1 Million.
According to the SEC Form 4 filings, Stephen P Squinto has made a total of 2 transactions in SpringWorks Therapeutics Inc (SWTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in SpringWorks Therapeutics Inc is the sale of 19,432 shares on April 28, 2021, which brought Stephen P Squinto around $1 Million.
Insider Trading History of Stephen P Squinto
- 1
Stephen P Squinto Trading Performance
GuruFocus tracks the stock performance after each of Stephen P Squinto's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen P Squinto is 28.57%. GuruFocus also compares Stephen P Squinto's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen P Squinto within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen P Squinto's insider trading performs compared to the benchmark.
Performance of Stephen P Squinto
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.38 | | | | | |
| Relative Return to S&P 500(%) | -16.12 | | | | | |
Stephen P Squinto Ownership Network
Ownership Network List of Stephen P Squinto
Ownership Network Relation of Stephen P Squinto
Stephen P Squinto Owned Company Details
What does SpringWorks Therapeutics Inc do?
Who are the key executives at SpringWorks Therapeutics Inc?
Stephen P Squinto is the director & 10 percent owner of SpringWorks Therapeutics Inc. Other key executives at SpringWorks Therapeutics Inc include director & Chief Executive Officer Saqib Islam , Chief Business Officer Badreddin Edris , and Chief People Officer Daniel Pichl .
SpringWorks Therapeutics Inc (SWTX) Insider Trades Summary
Over the past 18 months, Stephen P Squinto made no insider transaction in SpringWorks Therapeutics Inc (SWTX). Other recent insider transactions involving SpringWorks Therapeutics Inc (SWTX) include a net sale of 9,466 shares made by Julie Hambleton , a net sale of 98,000 shares made by Saqib Islam , and a net sale of 41,181 shares made by Daniel Pichl .
In summary, during the past 3 months, insiders sold 69,000 shares of SpringWorks Therapeutics Inc (SWTX) in total and bought 0 shares, with a net sale of 69,000 shares. During the past 18 months, 196,703 shares of SpringWorks Therapeutics Inc (SWTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,703 shares.
SpringWorks Therapeutics Inc (SWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
SpringWorks Therapeutics Inc Insider Transactions
Stephen P Squinto Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen P Squinto. You might contact Stephen P Squinto via mailing address: C/o Alexion Pharmaceuticals Inc, 352 Knotter Drive, Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
